Of note, the majority of ZNF217 target genes in B-ALL were found to be CoREST-independent targets, underscoring the significance of the CoREST-independent pathway for ZNF217's oncogenic role in B-ALL. The gene discussed is RCOR1; the disease is precursor B-cell acute lymphoblastic leukemia.